ChemicalBook > Product Catalog >Biologics >Biochemical Reagents >Inhibitor Activator >ICA 069673

ICA 069673

ICA 069673 Suppliers list
Company Name: VDM Biochemicals   
Tel: 0330-2528181
Email: sales@vdmbio.com
Company Name: Shanghai Lollane Biological Technology Co.,Ltd.  
Tel: 021-52996696,15000506266 15000506266
Email:
Company Name: EMMX Biotechnology LLC  
Tel: 888-539-0666
Email: info@emmx.com
Company Name: Shanghai EFE Biological Technology Co., Ltd.  
Tel: 021-65675885 18964387627
Email: info@efebio.com
Company Name: Shanghai YuanYe Biotechnology Co., Ltd.  
Tel: 15026964105
Email: 2881489226@qq.com
ICA 069673 Basic information
Product Name:ICA 069673
Synonyms:ICA 069673;N-(2-Chloro-5-pyrimidinyl)-3,4-difluorobenzamide;ICA069673;ICA-069673;Benzamide, N-(2-chloro-5-pyrimidinyl)-3,4-difluoro-;ICA-069673 >=98% (HPLC);Potassium Channel,ICA 069673,ICA-069673,KcsA,inhibit,Inhibitor;N-(2-Chloropyrimidin-5-yl)-3,4-difluorobenzamide;ICA-069673, 10 mM in DMSO
CAS:582323-16-8
MF:C11H6ClF2N3O
MW:269.63
EINECS:
Product Categories:Selective KCNQ2/Q3 potassium channel opener.
Mol File:582323-16-8.mol
ICA 069673 Structure
ICA 069673 Chemical Properties
Boiling point 358.9±37.0 °C(Predicted)
density 1.539±0.06 g/cm3(Predicted)
storage temp. Sealed in dry,Room Temperature
solubility DNF:30.0(Max Conc. mg/mL);111.26(Max Conc. mM)
DMSO:36.24(Max Conc. mg/mL);134.4(Max Conc. mM)
Ethanol:30.25(Max Conc. mg/mL);112.18(Max Conc. mM)
pka9.47±0.70(Predicted)
form Powder
color White to off-white
InChI1S/C11H6ClF2N3O/c12-11-15-4-7(5-16-11)17-10(18)6-1-2-8(13)9(14)3-6/h1-5H,(H,17,18)
InChIKeyIIBSHMFXVWTQSJ-UHFFFAOYSA-N
SMILESO=C(C1=CC=C(F)C(F)=C1)NC2=CN=C(Cl)N=C2
Safety Information
WGK Germany WGK 3
Storage Class11 - Combustible Solids
MSDS Information
ICA 069673 Usage And Synthesis
DescriptionICA 069673 is a heteromeric Kv7 channel activator. It is selective for Kv7.2/7.3 over Kv7.3/7.5 (EC50s = 0.69 and 14.3 μM, respectively) and also activates Kv7.4, Kv7.5, and heteromeric Kv7.4/7.5 channels in a dose-dependent manner. ICA 069673 has no activity against hERG, Nav1.5, and Kv7.1 cardiac ion channels (IC50s = >30 μM). Oral administration of ICA 069673 increases latency to first tonic-clonic seizure in the rat maximal electroshock and pentylentetrazol-induced seizure models (ED50s = 1.5 and <1 mg/kg, respectively). Formulations containing ICA 069673 are under clinical investigation for the treatment of epilepsy.
UsesICA-069673 is a KCNQ2/Q3 potassium channel activator. ICA-069673 demonstrates greater selectivity for KV7.2/7.3 over KV7.3/KV7.5, with EC50s of 0.69 μM and 14.3 μM, respectively. ICA-069673 inhibits spontaneous phasic and nerve-evoked contractions in guinea pig detrusor smooth muscle (DSM). ICA-069673 also decreases the global intracellular Ca(2+) concentration in DSM cells[1][2].
storageRoom temperature
References[1] Provence A, et al. The Novel KV7.2/KV7.3 Channel Opener ICA-069673 Reveals Subtype-Specific Functional Roles in Guinea Pig Detrusor Smooth Muscle Excitability and Contractility. J Pharmacol Exp Ther. 2015 Sep;354(3):290-301. DOI:10.1124/jpet.115.225268
ICA 069673 Preparation Products And Raw materials
Tag:ICA 069673(582323-16-8) Related Product Information
Benzamide, 3,4-difluoro-N-(2-methyl-5-pyrimidinyl)- (9CI) Benzamide, N-(2-chloro-5-pyrimidinyl)-3-fluoro- ICA 069673 2,2-Diphenyl-N-[4-(thiazol-2-ylsulfamoyl)-phenyl]-acetamide ICA N-(6-Chloropyridin-3-Yl)-3,4-Difluorobenzamide